BIO-RAD LABORATORIES, INC. (BIO-B)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, BIO-RAD LABORATORIES, INC. reported revenue of $2.58B, up 0.7% from the prior year. The company was profitable, with a net margin of 29.4% and a gross margin of 51.9%. It held $10.58B in total assets against $3.12B in total liabilities.
Key ratios (FY2025)
51.9%
Gross margin
1.8%
Operating margin
29.4%
Net margin
10.2%
Return on equity
+0.7%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.58B | $2.57B | $2.67B | $2.80B | $2.92B | $2.55B | $2.31B | $2.29B | $2.16B | $2.07B |
| Cost of Revenue | $1.24B | $1.19B | $1.24B | $1.23B | $1.28B | $1.11B | $1.05B | $1.07B | $972.45M | $929.74M |
| Gross Profit | $1.34B | $1.38B | $1.43B | $1.57B | $1.64B | $1.44B | $1.26B | $1.22B | $1.19B | $1.14B |
| Operating Income | $47.20M | $269.00M | $337.80M | $482.60M | $500.34M | $421.33M | $229.66M | -$103.34M | $119.25M | $55.72M |
| Net Income | $759.90M | -$1.84B | -$637.30M | -$3.63B | $4.25B | $3.81B | $1.76B | $365.61M | $122.25M | $26.00M |
| EPS (Diluted) | $27.85 | $-65.36 | $-21.82 | $-121.79 | $140.83 | $126.47 | $58.27 | $12.10 | $4.07 | $0.88 |
| Total Assets | $10.58B | $9.36B | $12.30B | $13.50B | $17.80B | $12.97B | $8.01B | $5.61B | $4.27B | $3.85B |
| Total Liabilities | $3.12B | $2.79B | $3.56B | $3.89B | $4.11B | $3.09B | $2.25B | $1.59B | $1.34B | $1.27B |
| Shareholders' Equity | $7.45B | $6.57B | $8.74B | $9.62B | $13.69B | $9.89B | $5.76B | $4.02B | $2.93B | $2.58B |
| Cash & Equivalents | $529.80M | $488.10M | $403.80M | $434.20M | $470.78M | $662.21M | $660.67M | $431.53M | $383.82M | $456.26M |
| Operating Cash Flow | $532.20M | $455.20M | $374.90M | $194.40M | $669.46M | $584.97M | $457.90M | $285.49M | $104.14M | $216.07M |
| Capital Expenditures | $157.60M | $165.60M | $156.70M | $112.80M | $133.75M | $108.56M | $98.53M | $129.82M | $111.33M | $141.44M |
| Shares Outstanding | 27.28M | 28.21M | 29.21M | 29.79M | 30.21M | 30.16M | 30.18M | 30.23M | 30.03M | 29.65M |